.png){kind=icon}
Return
Decrease post-transplant relapse using donor-derived expanded NK-cells
.png){kind=icon}
OA
AI
DOI：10.1038/s41375-021-01349-4.png)
.png){kind=icon}
.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
In this phase I/II clinical trial, we investigated the safety and efficacy of high doses of mb-IL21 ex vivo expanded donor-derived NK cells to decrease relapse in 25 patients with myeloid malignancies receiving haploidentical stem-cell transplantation (HSCT). Three doses of donor NK cells (1 x 10(5)-1 x 10(8) cells/kg/dose) were administered on days -2, +7, and +28. Results were compared with an independent contemporaneously treated case-matched cohort of 160 patients from the CIBMTR database. After a median follow-up of 24 months, the 2-year relapse rate was 4% vs. 38% (p = 0.014), and disease-free survival (DFS) was 66% vs. 44% (p = 0.1) in the cases and controls, respectively. Only one relapse occurred in the study group, in a patient with the high level of donor-specific anti-HLA antibodies (DSA) presented before transplantation. The 2-year relapse and DFS in patients without DSA was 0% vs. 40% and 72% vs. 44%, respectively with HR for DFS in controls of 2.64 (p = 0.029). NK cells in recipient blood were increased at day +30 in a dose-dependent manner compared with historical controls, and had a proliferating, mature, highly cytotoxic, NKG2C+/KIR+ phenotype. Administration of donor-derived expanded NK cells after haploidentical transplantation was safe, associated with NK cell-dominant immune reconstitution early post-transplant, preserved T-cell reconstitution, and improved relapse and DFS. TRIAL REGISTRATION: NCT01904136 (https://clinicaltrials.gov/ct2/show/NCT01904136).
Keywords:
TRANSPLANTATION
SURVIVAL
LEUKEMIA
DISEASE
MARROW
BLOOD
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
IF:
13.4
Papers:
1.1W
Citations:
3.1W
Organization
Cited Papers
ShareSaveShareSaveImpact of graft composition on outcomes of haploidentical bone marrow stem cell transplantation.png)
HAEMATOLOGICAOAAI
HAEMATOLOGICAIF7.9
OAAIShareSaveNuclear DNA amount and genome downsizing in natural and synthetic allopolyploids of the generaAegilopsandTriticumGenome
GenomeIF0
PREAI
ShareSaveShareSave
View more